Adamis Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Adamis Pharmaceuticals
Q3 2023
14 Nov, 2023
Q2 2023
21 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adamis Pharmaceuticals Corporation
Access all reports
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing therapeutic products in allergy, respiratory, and opioid overdose treatment. Its portfolio includes prescription medicines and drug-device combination products, such as epinephrine injectors for severe allergic reactions and naloxone for opioid overdose reversal. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
ADMP
Country
🇺🇸 United States